Key result
Electroceuticals, which target neural circuits via implantable devices, have potential future applications in cardiology including heart failure, arrhythmias, and coronary artery disease.
Electroceuticals represent a novel therapeutic approach targeting neural circuits with potential future applications across various cardiovascular conditions.
Electroceuticals are a new category of therapeutic agents which act by targeting the neural circuits of organs. The therapy involves mapping the neural circuitry and delivering neural impulses to these specific targets. The impulse is administered via an implantable device. In cardiology besides pacemaker, defibrillation and resynchronization applications it could have usefulness in heart failure, atrial fibrillation, coronary artery disease, myocarditis, resistant hypertension, atrial and ventricular tachyarrhythmias, pulseless electrical activity, and refractory angina.
No takes yet. Share an insight, caveat, or question.
Sundeep Mishra (2017) conducted a review in Cardiovascular diseases. Electroceuticals was evaluated. Electroceuticals, which target neural circuits via implantable devices, have potential future applications in cardiology including heart failure, arrhythmias, and coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: